Hers vs Remedy Meds
Hers costs $100 less a month, and both sell semaglutide and tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Hers
Best for: coverage in all 50 states, which most sellers will not confirm
Visit Hers →
If you are choosing between Hers and Remedy Meds, the first difference is cost: Hers is $100 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Hers leads our six-part score, 7.0 to 5.1. One of the two has an FDA warning letter on record, covered below.
Hers vs Remedy Meds price
Hers is the cheaper way in: $199 a month against $299 a month at Remedy Meds. That is $100 less each month (33% lower), or about $1,200 over a year of treatment.
Drug by drug: Semaglutide is cheaper at Hers ($199 a month vs $299 a month); tirzepatide is cheaper at Hers ($299 a month vs $399 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format, Hers prices compounded injections and brand-name pens, while Remedy Meds prices compounded injections.
If you want the FDA-approved brand rather than a compounded version, Hers is the only one of the two with a brand-name price.
Where each one treats patients
Hers lists 50 states, and Remedy Meds does not publish where it ships.
Pricing
Hers
Brand Zepbound from $299/mo medication-only; requires Hers Weight Loss Membership ($149/mo)
Remedy Meds
What each price covers
Both prices cover the medication itself.
Remedy Meds' price also covers the clinician visit and shipping, which Hers does not claim.
Hers is silent on shipping and lab work.
Remedy Meds is silent on lab work and coaching.
Hers
Covered by the monthly price
Medication
In the price
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Not stated
Coaching
Charged on top
Remedy Meds
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Where each one scores higher
Overall, Hers scores 7.0 and Remedy Meds 5.1 out of 10.
Hers is stronger on user experience (8.0 vs 3.0), trust & safety (8.5 vs 1.0) and accessibility (10.0 vs 5.0).
Remedy Meds is stronger on support (7.0 vs 3.0).
Value and effectiveness are within half a point.
Hers
7.0/10
Remedy Meds
5.1/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent Remedy Meds a warning letter dated September 9, 2025 (letter 716830), and it is still open.
Hers has no FDA warning letter on record with us.
Features & Coverage
| Feature | Hers | Remedy Meds |
|---|---|---|
| Starting Price | ✓$199/mo | $299/mo |
| Features | 2 features | ✓3 features |
| States Available | 50 | Not disclosed |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | ✓None | 1 letter |
About Hers
Hers is the women-focused telehealth brand from Hims and Hers. It sells compounded semaglutide on a 6-month plan.
Read our full Hers review →About Remedy Meds
Remedy Meds sells compounded semaglutide and tirzepatide programs through telehealth.
Read our full Remedy Meds review →Pros & Cons
Hers
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication
- Serves all 50 states
- We found no FDA warning letters issued to Hers
Watch-outs
- Not included in the monthly price: clinician visits, coaching
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Remedy Meds
What we like
- The monthly price includes the medication, clinician visits and shipping
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued Remedy Meds a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Hers wins this one, 7.0 to 5.1, above all for coverage in all 50 states, which most sellers will not confirm. It also costs $100 less each month than Remedy Meds.
Choose Hers if…
You want coverage in all 50 states, which most sellers will not confirm and an opening price near $199 a month.
Choose Remedy Meds if…
You want broader feature coverage and an opening price near $299 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Breeze Meds
Knowing which pharmacy fills the vial: it names Belmar Pharmacy
From $199/mo
Get started →HealthRX
Compounded semaglutide at $133/month
From $133/mo
Get started →RNK Health
An oral route if you will not self-inject
From $197/mo
Get started →Hers vs Remedy Meds: FAQ
Close alternatives to Hers and Remedy Meds
- Hers vs Hims
- Hers vs Noom
- Hers vs Care Bare Rx
- Hers vs Concierge MD LA
- Remedy Meds vs Willow
- Remedy Meds vs Apex MD
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.